(Bloomberg) -- Nikola Corp. has finally reignited some of the fervor of its once die hard day-trading fans.Most Read from BloombergThe electric-vehicle maker...
Biotech stocks make for an interesting study. They represent a high-risk sector, characterized by famously high overhead and long lead times to develop...
Acadia Pharmaceuticals (ACAD) obliterated Wall Street's expectations for the launch quarter of its Rett syndrome treatment and, on Friday, ACAD stock hit a...